UniProt | Protein Name |
---|---|
Q9NRR6 |
|
GO Term | Evidence Code | PMID |
---|---|---|
biological_process | ||
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | ||
phosphatidylinositol-3-phosphate biosynthetic process | ||
phosphatidylinositol biosynthetic process |
|
|
negative regulation of translation |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110140 | Bardet-Biedl syndrome 18 | |
DOID:0110141 | Bardet-Biedl syndrome 19 | |
DOID:0110213 | isolated cleft palate | |
DOID:0110594 | primary ciliary dyskinesia 1 | |
DOID:0110861 | autosomal recessive polycystic kidney disease | |
DOID:0110980 | Joubert syndrome 1 | |
DOID:10426 | Klippel-Feil syndrome | |
DOID:10487 | Hirschsprung's disease | |
DOID:1056 | oculocerebrorenal syndrome | |
DOID:1059 | intellectual disability |
HPO ID | HPO Term |
---|---|
HP:0000003 | Multicystic kidney dysplasia |
HP:0000007 | Autosomal recessive inheritance |
HP:0000023 | Inguinal hernia |
HP:0000054 | Micropenis |
HP:0000077 | Abnormality of the kidney |
HP:0000083 | Renal insufficiency |
HP:0000107 | Renal cyst |
HP:0000112 | Nephropathy |
HP:0000158 | Macroglossia |
HP:0000175 | Cleft palate |
Disease ID | Disease Name |
---|---|
ORPHA:75858 |
|
ORPHA:475 |
|
OMIM:213300 |
|
ORPHA:220493 |
|
OMIM:610156 |
|
ORPHA:1454 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
100699689 | ORENI10172 | ||
115581894 | SPAAU15442 | ||
100216253 | Xenbase:XB-GENE-986385 | ||
101940841 | CHRPI11071 | ||
109314015 | CROPO20300 | ||
100546617 | MELGA05302 | ||
103818950 | SERCA14433 | ||
100092732 | ORNAN21028 | ||
100930476 | SARHA15827 | ||
100399977 | CALJA18709 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024